The recently passed Wisconsin state budget will expand a collaborative network of the UW Carbone Cancer Center and cancer doctors around the state to help find treatments matched to the genetic differences in patients' cancer. 

A total of $980,000 has been allocated in to expand the reach of the Precision Medicine Molecular Tumor Board (PMMTB) to reach all Wisconsin cancer patients who may need a genetically customized approach to their treatment. 

"This will allow us to work with even more of the great cancer providers and clinics around the state to make sure even more Wisconsin residents who suffer from cancer benefit from our research and expertise," said Howard Bailey, MD (pictured at upper right), professor, Hematology, Medical Oncology and Palliative Care and director of the Carbone Cancer Center. 

"These new resources will allow us to handle exponentially more cases and share knowledge among providers, genetics experts and patients across the state," said Mark Burkard, MD, PhD (pictured at lower right), associate professor, Hematology, Medical Oncology and Palliative Care and medical director of the PMMTB.

Resources:

• "State Budget Expands Precision Medicine to Wisconsin Cancer Patients," UW Health, September 21, 2017
• Channel 3000 News Update - see timestamp 16:10